<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Llorente X</submitter><funding>Spanish Ministry of Science and Innovation</funding><pagination>8053</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10179084</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>24(9)</volume><pubmed_abstract>Nanocarriers, and especially nanostructured lipid carriers (NLC), represent one of the most effective systems for topical drug administration. NLCs are biodegradable, biocompatible and provide a prolonged drug release. The glutamate release inhibitor Riluzole (RLZ) is a drug currently used for amyotrophic lateral sclerosis (ALS), with anti-proliferative effects potentially beneficial for diseases with excessive cell turnover. However, RLZ possesses low water solubility and high light-sensibility. We present here optimized NLCs loaded with RLZ (RLZ-NLCs) as a potential topical treatment. RLZ-NLCs were prepared by the hot-pressure homogenization method using active essential oils as liquid lipids, and optimized using the design of experiments approach. RLZ-NLCs were developed obtaining optim</pubmed_abstract><journal>International journal of molecular sciences</journal><pubmed_title>Riluzole-Loaded Nanostructured Lipid Carriers for Hyperproliferative Skin Diseases.</pubmed_title><pmcid>PMC10179084</pmcid><funding_grant_id>PID2021-122187NB-C32</funding_grant_id><funding_grant_id>PID2021-126249OA-I00</funding_grant_id><funding_grant_id>PID2020-114477RB-I00</funding_grant_id><pubmed_authors>Bonilla L</pubmed_authors><pubmed_authors>Agudelo MG</pubmed_authors><pubmed_authors>Llorente X</pubmed_authors><pubmed_authors>Manils J</pubmed_authors><pubmed_authors>Sanchez-Lopez E</pubmed_authors><pubmed_authors>Garcia ML</pubmed_authors><pubmed_authors>Pujol M</pubmed_authors><pubmed_authors>Lopez-Ramajo D</pubmed_authors><pubmed_authors>Soler C</pubmed_authors><pubmed_authors>Espina M</pubmed_authors><pubmed_authors>Gong RC</pubmed_authors><pubmed_authors>Filgaira I</pubmed_authors><pubmed_authors>Esteruelas G</pubmed_authors></additional><is_claimable>false</is_claimable><name>Riluzole-Loaded Nanostructured Lipid Carriers for Hyperproliferative Skin Diseases.</name><description>Nanocarriers, and especially nanostructured lipid carriers (NLC), represent one of the most effective systems for topical drug administration. NLCs are biodegradable, biocompatible and provide a prolonged drug release. The glutamate release inhibitor Riluzole (RLZ) is a drug currently used for amyotrophic lateral sclerosis (ALS), with anti-proliferative effects potentially beneficial for diseases with excessive cell turnover. However, RLZ possesses low water solubility and high light-sensibility. We present here optimized NLCs loaded with RLZ (RLZ-NLCs) as a potential topical treatment. RLZ-NLCs were prepared by the hot-pressure homogenization method using active essential oils as liquid lipids, and optimized using the design of experiments approach. RLZ-NLCs were developed obtaining optim</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Apr</publication><modification>2025-04-18T13:56:57.821Z</modification><creation>2025-04-06T23:49:27.842Z</creation></dates><accession>S-EPMC10179084</accession><cross_references><pubmed>37175765</pubmed><doi>10.3390/ijms24098053</doi></cross_references></HashMap>